MELVILLE, N.Y. — August 5, 2025 — Leads & Copy — BioRestorative Therapies, Inc. (NASDAQ:BRTX) will release its second quarter 2025 financial results after market close on Tuesday, August 12, 2025. Following the announcement, BioRestorative management will host a conference call to review the financial results and provide a business update.
The conference call will be held on Tuesday, August 12, 2025, at 4:30 p.m. ET. Domestic callers can dial 1-888-506-0062, and international callers can dial 1-973-528-0011, using access code 436077. The call will also be broadcast live and archived on the Company’s website.
BioRestorative develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The company’s two core clinical development programs relate to the treatment of disc/spine disease and metabolic disorders, and it also operates a commercial BioCosmeceutical platform.
Stephen Kilmer, Investor Relations, can be reached at (646) 274-3580 or skilmer@biorestorative.com.
Source: BioRestorative
